A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Pulmonary Embolism
Related studies linked through entity extraction aliases.
VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis
- Status
- COMPLETED
- Phase
- NA
Catheter Thrombectomy in Patients With Massive Pulmonary Embolism
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Diagnosis and Pathophysiology of Pulmonary Embolism (APE 1 Trial)
- Status
- TERMINATED
- Phase
- NA
D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence
- Status
- COMPLETED
- Phase
- N/A
D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism
- Status
- COMPLETED
- Phase
- PHASE4
Odiparcil For The Prevention Of Venous Thromboembolism
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Investigation of Pulmonary Embolism Diagnosis III
- Status
- COMPLETED
- Phase
- N/A
Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)
- Status
- COMPLETED
- Phase
- PHASE4
Aspirin for the Prevention of Recurrent Venous Thromboembolism
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Tenecteplase Pulmonary Embolism Italian Study
- Status
- TERMINATED
- Phase
- PHASE2
Home Treatment of Pulmonary Embolism
- Status
- UNKNOWN
- Phase
- PHASE4
SHORTness of Breath In the Emergency Department (SHORTIE)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter
- Status
- COMPLETED
- Phase
- PHASE4
Strategies for Suspected Pulmonary Embolism in Emergency Departments
- Status
- COMPLETED
- Phase
- NA
The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial
- Status
- COMPLETED
- Phase
- PHASE4
Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure
- Status
- TERMINATED
- Phase
- NA
Fixed Dose Heparin Study
- Status
- COMPLETED
- Phase
- PHASE3
D-Dimer and IPG for Recurrent Thrombosis (DIRECT)
- Status
- TERMINATED
- Phase
- PHASE3
Genetic Determinants of Warfarin Anticoagulation Effect
- Status
- UNKNOWN
- Phase
- NA